Friend or foe? A systematic evaluation of NKT and NK cells as prognostic markers in colorectal carcinoma

Hao Feng,Huan Tong,Wolfgang Thasler,Qiang Xia
DOI: https://doi.org/10.4049/jimmunol.204.supp.72.13
2020-01-01
The Journal of Immunology
Abstract:Abstract BACKGROUND Natural killer t(NKT) cells and Natural killer (NK) cells orchestrate immune responses in tumor progression. NKT and NK cells have been suggested as prognostic markers for cancer patients. However, the results were controversial. In the present study, we present a systematic review and meta-analysis of studies assessing the prognostic value of NKT and NK cells in colorectal cancers, respectively. METHODS We performed a systematic literature search and included studies using immunofluorescence or flow cytometry and survival analysis to assess the prognostic value of NKT and NK cells in colorectal cancer. We performed a meta-analysis of studies providing necessary statistical data and investigated prognostic value of NKT and NK cells. RESULTS Of the 275 articles identified, 169 were eligible for this systematic review, and eight were included in the meta-analysis. Both NKT and NK cells were the most promising predictors of disease-free survival (DFS) and overall survival (OS) in colorectal cancer patients. Both NKT-high and NK-high were positively correlated to better OS, respectively (NKT: p=0.002, HR 2.91, 95%CI 1.46~5.80; NK: p<0.0001, HR 3.87, 95%CI 1.97–7.62). Intriguingly, NK-high was also associated with better DFS (NK: p<0.0001, HR 3.42, 95%CI 2.05–5.69); however, NKT-high presented the opposite trend for DFS(NKT: p<0.0001, HR 5.28, 95%CI 2.35–11.84). CONCLUSION Proper reporting of the association between NKT/NK allows the reader to evaluate the quality and reliability of the previously reported data. The promising results might boost the interest in tumor immunology such as CAR-NK and CAR-NKT. The prognostic value of NKT and NK cells should be validated in large, standardized studies.
What problem does this paper attempt to address?